Anda di halaman 1dari 1

33764 Federal Register / Vol. 72, No.

117 / Tuesday, June 19, 2007 / Notices

Estimated Total Annual Burden speakerphone will be provided at the the meeting. Background material is
Hours: 630. specified location for public available at http://www.fda.gov/ohrms/
Additional Information: Copies of the participation in the meeting. Important dockets/ac/acmenu.htm, click on the
proposed collection may be obtained by information about transportation and year 2007 and scroll down to the
writing to the Administration for directions to the NIH campus, parking, appropriate advisory committee link.
Children and Families, Office of and security procedures is available on Procedure: On July 26, 2007, from 11
Administration, Office of Information the Internet at http://www.nih.gov/ a.m. to approximately 2 p.m., the
Services, 370 L’Enfant Promenade, SW., about/visitor/index.htm. Visitors must meeting is open to the public. Interested
Washington, DC 20447, Attn: ACF show two forms of identification, one of persons may present data, information,
Reports Clearance Officer. All requests which must be a government-issued or views, orally or in writing, on issues
should be identified by the title of the photo identification such as a Federal pending before the committee. Written
information collection. E-mail address: employee badge, driver’s license, submissions may be made to the contact
infocollection@acf.hhs.gov. passport, green card, etc. If you are person on or before July 12, 2007. Oral
OMB Comment: OMB is required to planning to drive to and park on the presentations from the public will be
make a decision concerning the NIH campus, you must enter at the scheduled between approximately 1
collection of information between 30 South Dr. entrance of the campus which p.m. and 2 p.m. Those desiring to make
and 60 days after publication of this is located on Wisconsin Ave. (the formal oral presentations should notify
document in the Federal Register. Medical Center Metro entrance), and the contact person and submit a brief
Therefore, a comment is best assured of allow extra time for vehicle inspection. statement of the general nature of the
having its full effect if OMB receives it Detailed information about security evidence or arguments they wish to
within 30 days of publication. Written procedures is located at http:// present, the names and addresses of
comments and recommendations for the www.nih.gov/about/visitorsecurity.htm. proposed participants, and an
proposed information collection should Due to the limited available parking, indication of the approximate time
be sent directly to the following: Office visitors are encouraged to use public requested to make their presentation on
of Management and Budget, Paperwork transportation. or before July 18, 2007. Time allotted for
Reduction Project, FAX: 202–395–6974, Contact Person: Gail Dapolito or each presentation may be limited. If the
Attn: Desk Officer for the Danielle Cubbage, Center for Biologics number of registrants requesting to
Administration for Children and Evaluation and Research, Food and speak is greater than can be reasonably
Families. Drug Administration, 1401 Rockville accommodated during the scheduled
Pike, Rockville, MD, 20852, 301–827– open public hearing session, FDA may
Dated: June 14, 2007.
0314, or FDA Advisory Committee conduct a lottery to determine the
Robert Sargis, Information Line, 1–800–741–8138 speakers for the scheduled open public
Reports Clearance Officer. (301–443–0572 in the Washington, DC hearing session. The contact person will
[FR Doc. 07–3004 Filed 6–18–07; 8:45 am] area), code 3014512389. Please call the notify interested persons regarding their
BILLING CODE 4184–01–M Information Line for up-to-date request to speak by July 19, 2007.
information on this meeting. A notice in Closed Committee Deliberations: On
the Federal Register about last minute July 26, 2007, from approximately 2:15
DEPARTMENT OF HEALTH AND modifications that impact a previously p.m. to 3:30 p.m., the meeting will be
HUMAN SERVICES announced advisory committee meeting closed to permit discussion where
cannot always be published quickly disclosure would constitute a clearly
Food and Drug Administration enough to provide timely notice. unwarranted invasion of personal
Therefore, you should always check the privacy (5 U.S.C. 552b(c)(6)). The
Cellular, Tissue, and Gene Therapies
agency’s Web site and call the committee will discuss reports of
Advisory Committee; Notice of Meeting
appropriate advisory committee hot intramural research programs and make
AGENCY: Food and Drug Administration, line/phone line to learn about possible recommendations regarding personnel
HHS. modifications before coming to the staffing decisions.
ACTION: Notice. meeting. Persons attending FDA’s advisory
Agenda: On July 26, 2007, the committee meetings are advised that the
This notice announces a forthcoming committee will meet in open session to agency is not responsible for providing
meeting of a public advisory committee hear updates of research programs in: access to electrical outlets.
of the Food and Drug Administration (1) The Division of Therapeutic Proteins FDA welcomes the attendance of the
(FDA). At least one portion of the and the Division of Monoclonal public at its advisory committee
meeting will be closed to the public. Antibodies, Office of Biotechnology meetings and will make every effort to
Name of Committee: Cellular, Tissue, Products, Center for Drug Evaluation accommodate persons with physical
and Gene Therapies Advisory and Research, FDA and (2) the Division disabilities or special needs. If you
Committee. of Cellular and Gene Therapies, Office require special accommodations due to
General Function of the Committee: of Cellular, Tissue, and Gene Therapies, a disability, please contact Gail Dapolito
To provide advice and Center for Biologics Evaluation and at least 7 days in advance of the
recommendations to the agency on Research, FDA. meeting.
FDA’s regulatory issues. FDA intends to make background Notice of this meeting is given under
Date and Time: The meeting will be material available to the public no later the Federal Advisory Committee Act (5
held by teleconference on July 26, 2007 than 2 business days before the meeting. U.S.C. app. 2).
from 11 a.m. to approximately 3:15 p.m. If FDA is unable to post the background
Location: National Institutes of material on its Web site prior to the Dated: June 11, 2007.
rwilkins on PROD1PC63 with NOTICES

Health, Bldg. 29B, Conference rms. A/B, meeting, the background material will Randall W. Lutter,
9000 Rockville Pike, Bethesda, MD. This be made publicly available at the Associate Commissioner for Policy and
meeting will be held by teleconference. location of the advisory committee Planning.
The public is welcome to attend the meeting, and the background material [FR Doc. E7–11728 Filed 6–18–07; 8:45 am]
meeting at the specified location. A will be posted on FDA’s Web site after BILLING CODE 4160–01–S

VerDate Aug<31>2005 18:32 Jun 18, 2007 Jkt 211001 PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 E:\FR\FM\19JNN1.SGM 19JNN1